BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Russo EB, Cuttler C, Cooper ZD, Stueber A, Whiteley VL, Sexton M. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. Cannabis Cannabinoid Res 2021. [PMID: 34569849 DOI: 10.1089/can.2021.0058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Andreis K, Billingsley J, Naimi Shirazi K, Wager-miller J, Johnson C, Bradshaw H, Straiker A. Cannabinoid CB1 receptors regulate salivation. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-17987-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Colvin EK, Hudson AL, Anderson LL, Kumar RP, McGregor IS, Howell VM, Arnold JC. An Examination of the Anti-Cancer Properties of Plant Cannabinoids in Preclinical Models of Mesothelioma. Cancers (Basel) 2022;14:3813. [PMID: 35954477 DOI: 10.3390/cancers14153813] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Anokwuru CP, Makolo FL, Sandasi M, Tankeu SY, Elisha IL, Agoni C, Combrinck S, Viljoen A. Cannabigerol: a bibliometric overview and review of research on an important phytocannabinoid. Phytochem Rev. [DOI: 10.1007/s11101-021-09794-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]